NewLife Medical Aesthetics Ltd

NewLife Medical Aesthetics Ltd
Statement of Financial Position
As at 31 March 2025

	2025		2024
	£	£	£	£
Fixed assets		83,454		110,482
Current assets	21,740		44,754
Creditors: amount falling due within one year	(87,803)		(78,611)
Net current assets		(66,063)		(33,857)
Total assets less current liabilities		17,391		76,625
Creditors: amount falling due after more than one year		(20,879)		(64,656)
Provisions for liabilities		(130)		(338)
Net assets		(3,618)		11,631


Capital and reserves		(3,618)		11,631

NOTES TO THE ACCOUNTS

General Information

NewLife Medical Aesthetics Ltd is a private company, limited by shares, registered in England and Wales, registration number 11248596, registration address 42 Coombe Lane, London, SW20 0LA.

Accounting policies

Significant accounting policies

Statement of compliance

These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.

The financial statements are prepared in sterling which is the functional currency of the company.

2.	Average number of employees Average number of employees during the year was 3 (2024 : 1).

For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The financial statements were approved by the director on 04 June 2025 and were signed by:

--------------------------------
Musharraf Ashraf
Director


Registered Number: 11248596
England and Wales
NEWLIFE MEDICAL AESTHETICS LTD

Unaudited Financial Statements

Period of accounts Start date: 01 April 2024 End date: 31 March 2025